[Treatment of acute leukosis in children with arabinosyl cytosine].
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D001792:Blood Platelets; D001803:Blood Transfusion; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000097:blood / Q000188:drug therapy* / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy* / Q000628:therapy; D012075:Remission, Spontaneous
D000900:Anti-Bacterial Agents; D003561:Cytarabine; D001215:Asparaginase
Zur Behandlung der akuten Leukosen im Kindesalter mit Arabinosylcytosin.